You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 24, December 27, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (104)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Alert me on articles by topic

Emergence of Domestically Acquired Ceftriaxone-Resistant Salmonella Infections Associated With AmpC {beta}-Lactamase

Eileen F. Dunne, MD, MPH; Paul D. Fey, PhD; Pat Kludt, MPH; Roshan Reporter, MD, MPH; Farzad Mostashari, MD, MSPH; Pam Shillam, MPH; Julie Wicklund, MPH; Corinne Miller, MPH; Ben Holland, BS; Karen Stamey, BS; Timothy J. Barrett, PhD; James K. Rasheed, PhD; Fred C. Tenover, PhD; Efrain M. Ribot, PhD; Frederick J. Angulo, DVM, PhD

JAMA. 2000;284:3151-3156.

Context  Ceftriaxone, an expanded-spectrum cephalosporin, is an antimicrobial agent commonly used to treat severe Salmonella infections, especially in children. Ceftriaxone-resistant Salmonella infections have recently been reported in the United States, but the extent of the problem is unknown.

Objectives  To summarize national surveillance data for ceftriaxone-resistant Salmonella infections in the United States and to describe mechanisms of resistance.

Design and Setting  Case series and laboratory evaluation of human isolates submitted to the Centers for Disease Control and Prevention from 17 state and community health departments participating in the National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria between 1996 and 1998.

Patients  Patients with ceftriaxone-resistant Salmonella infections between 1996 and 1998 were interviewed and isolates with decreased ceftriaxone susceptibility were further characterized.

Main Outcome Measures  Exposures and illness outcomes, mechanisms of resistance.

Results  The prevalence of ceftriaxone-resistant Salmonella was 0.1% (1 of 1326) in 1996, 0.4% (5 of 1301) in 1997, and 0.5% (7 of 1466) in 1998. Ten (77%) of the 13 patients with ceftriaxone-resistant infections were aged 18 years or younger. The patients lived in 8 states (California, Colorado, Kansas, Massachusetts, Maryland, Minnesota, New York, and Oregon). Nine (82%) of 11 patients interviewed did not take antimicrobial agents and 10 (91%) did not travel outside the United States before illness onset. Twelve of the 15 Salmonella isolates with ceftriaxone minimum inhibitory concentrations of 16 µg/mL or higher were serotype Typhimurium but these isolates had different pulsed-field gel electrophoresis patterns. Thirteen of these 15 isolates collected between 1996 and 1998 were positive for a 631–base pair polymerase chain reaction product obtained by using primers specific for the ampC gene of Citrobacter freundii.

Conclusions  Domestically acquired ceftriaxone-resistant Salmonella has emerged in the United States. Most ceftriaxone-resistant Salmonella isolates had similar AmpC plasmid-mediated resistance.


Author Affiliations: Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases (Drs Dunne, Barrett, Rasheed, Ribot, and Angulo, and Mr Holland and Ms Stamey) and Hospital Infections Program, Nosocomial Pathogens Laboratory Branch (Dr Tenover), National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga; Section of Infectious Diseases, University of Nebraska Medical Center, Omaha (Dr Fey); Massachusetts Department of Public Health, Boston (Ms Kludt); Los Angeles County Health Department, Los Angeles, Calif (Dr Reporter); New York City Department of Health, New York, NY (Dr Mostashari); Colorado Department of Public Health and Environment, Denver (Ms Shillam); Minnesota Department of Health, St Paul (Ms Wicklund); and the Kansas Department of Health and Environment, Topeka (Ms Miller).


RELATED ARTICLE

December 27, 2000
JAMA. 2000;284(24):3237-3238.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emergence of CTX-M-15 type extended-spectrum {beta}-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates
Rotimi et al.
J Med Microbiol 2008;57:881-886.
ABSTRACT | FULL TEXT  

Isolation of Salmonella enterica Serotype Newport from a Partly Ruptured Splenic Abscess in a Traveler Returning from Zanzibar
Tappe et al.
J. Clin. Microbiol. 2007;45:3115-3117.
ABSTRACT | FULL TEXT  

Survival of Salmonella enterica Serovar Newport in Manure and Manure-Amended Soils
You et al.
Appl. Environ. Microbiol. 2006;72:5777-5783.
ABSTRACT | FULL TEXT  

Variability in the Region Downstream of the blaCMY-2 {beta}-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids.
Kang et al.
Antimicrob. Agents Chemother. 2006;50:1590-1593.
ABSTRACT | FULL TEXT  

Distribution of a transposon-like element carrying blaCMY-2 among Salmonella and other Enterobacteriaceae
Su et al.
J Antimicrob Chemother 2006;57:424-429.
ABSTRACT | FULL TEXT  

High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002
Sivapalasingam et al.
Antimicrob. Agents Chemother. 2006;50:49-54.
ABSTRACT | FULL TEXT  

Detection of a blaSHV Extended-Spectrum {beta}-Lactamase in Salmonella enterica Serovar Newport MDR-AmpC
Rankin et al.
J. Clin. Microbiol. 2005;43:5792-5793.
ABSTRACT | FULL TEXT  

Ceftiofur-Resistant Salmonella Strains Isolated from Dairy Farms Represent Multiple Widely Distributed Subtypes That Evolved by Independent Horizontal Gene Transfer
Alcaine et al.
Antimicrob. Agents Chemother. 2005;49:4061-4067.
ABSTRACT | FULL TEXT  

Ceftriaxone Resistance of Nontyphoidal Salmonella enterica Isolates in Northern Taiwan Attributable to Production of CTX-M-14 and CMY-2 {beta}-Lactamases
Li et al.
J. Clin. Microbiol. 2005;43:3237-3243.
ABSTRACT | FULL TEXT  

Repeated Occurrence of Diverse Extended-Spectrum {beta}-Lactamases in Minor Serotypes of Food-Borne Salmonella enterica subsp. enterica
Politi et al.
J. Clin. Microbiol. 2005;43:3453-3456.
ABSTRACT | FULL TEXT  

Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan
Su et al.
J Antimicrob Chemother 2005;55:846-852.
ABSTRACT | FULL TEXT  

The New {beta}-Lactamases
Jacoby and Munoz-Price
NEJM 2005;352:380-391.
FULL TEXT  

Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals
Mulvey et al.
Antimicrob. Agents Chemother. 2005;49:358-365.
ABSTRACT | FULL TEXT  

Nontherapeutic Use of Antimicrobial Agents in Animal Agriculture: Implications for Pediatrics
Shea et al.
Pediatrics 2004;114:862-868.
ABSTRACT | FULL TEXT  

Multiple Outbreaks of Nosocomial Salmonellosis in Russia and Belarus Caused by a Single Clone of Salmonella enterica Serovar Typhimurium Producing an Extended-Spectrum {beta}-Lactamase
Edelstein et al.
Antimicrob. Agents Chemother. 2004;48:2808-2815.
ABSTRACT | FULL TEXT  

DNA Sequence Analysis of Regions Surrounding blaCMY-2 from Multiple Salmonella Plasmid Backbones
Giles et al.
Antimicrob. Agents Chemother. 2004;48:2845-2852.
ABSTRACT | FULL TEXT  

Extended-Spectrum-Cephalosporin Resistance in Salmonella enterica Isolates of Animal Origin
Gray et al.
Antimicrob. Agents Chemother. 2004;48:3179-3181.
ABSTRACT | FULL TEXT  

Bacteremia Due to Salmonella enterica Serotype Montevideo Producing Plasmid-Mediated AmpC {beta}-Lactamase (DHA-1)
Kim et al.
Annals of Clinical & Laboratory Science 2004;34:214-217.
ABSTRACT | FULL TEXT  

Characterization of Multiple-Antimicrobial-Resistant Salmonella Serovars Isolated from Retail Meats
Chen et al.
Appl. Environ. Microbiol. 2004;70:1-7.
ABSTRACT | FULL TEXT  

Characterization of Salmonella enterica Serotype Newport Isolated from Humans and Food Animals
Zhao et al.
J. Clin. Microbiol. 2003;41:5366-5371.
ABSTRACT | FULL TEXT  

Association between Handling of Pet Treats and Infection with Salmonella enterica Serotype Newport Expressing the AmpC {beta}-Lactamase, CMY-2
Pitout et al.
J. Clin. Microbiol. 2003;41:4578-4582.
ABSTRACT | FULL TEXT  

Molecular Epidemiology and Characterization of Plasmid-Encoded {beta}-Lactamases Produced by Tunisian Clinical Isolates of Salmonella enterica Serotype Mbandaka Resistant to Broad-Spectrum Cephalosporins
Makanera et al.
J. Clin. Microbiol. 2003;41:2940-2945.
ABSTRACT | FULL TEXT  

Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens
Byington et al.
Pediatrics 2003;111:964-968.
ABSTRACT | FULL TEXT  

Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 {beta}-Lactamase Production
Armand-Lefevre et al.
Antimicrob. Agents Chemother. 2003;47:1165-1168.
ABSTRACT | FULL TEXT  

In Vivo Acquisition of Ceftriaxone Resistance in Salmonella enterica Serotype Anatum
Su et al.
Antimicrob. Agents Chemother. 2003;47:563-567.
ABSTRACT | FULL TEXT  

Molecular Characterization of Cephalosporin-Resistant Salmonella enterica Serotype Newport Isolates from Animals in Pennsylvania
Rankin et al.
J. Clin. Microbiol. 2002;40:4679-4684.
ABSTRACT | FULL TEXT  

Characterization of Multidrug-Resistant Escherichia coli Isolates Associated with Nosocomial Infections in Dogs
Sanchez et al.
J. Clin. Microbiol. 2002;40:3586-3595.
ABSTRACT | FULL TEXT  

Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 {beta}-lactamases
Hanson et al.
J Antimicrob Chemother 2002;49:1011-1014.
ABSTRACT | FULL TEXT  

Characterization of Plasmids Carrying CMY-2 from Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains Isolated in the United States between 1996 and 1998
Carattoli et al.
Antimicrob. Agents Chemother. 2002;46:1269-1272.
ABSTRACT | FULL TEXT  

Plasmid-Determined AmpC-Type {beta}-Lactamases
Philippon et al.
Antimicrob. Agents Chemother. 2002;46:1-11.
FULL TEXT  

Identification and Expression of Cephamycinase blaCMY Genes in Escherichia coli and Salmonella Isolates from Food Animals and Ground Meat
Zhao et al.
Antimicrob. Agents Chemother. 2001;45:3647-3650.
ABSTRACT | FULL TEXT  

The Isolation of Antibiotic-Resistant Salmonella from Retail Ground Meats
White et al.
NEJM 2001;345:1147-1154.
ABSTRACT | FULL TEXT  

Evidence for Transfer of CMY-2 AmpC {beta}-Lactamase Plasmids between Escherichia coli and Salmonella Isolates from Food Animals and Humans
Winokur et al.
Antimicrob. Agents Chemother. 2001;45:2716-2722.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.